Supercritical fluid fabrication of components for a sustained-release injectable risperidone dose form


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The process of supercritical fluid encapsulation of pharmaceutical grade risperidone into bioresorbable D,L-polylactide microparticles via the PGSS (Particles from Gas-Saturated Solutions) method was examined. Micronization and changes in the morphology of risperidone crystals during its encapsulation into a polymer plasticized with supercritical carbon dioxide were experimentally observed. This result made it possible to prepare the polymer structures of various dispersities (from 10 to 100 μm) and morphologies containing up to 40 wt % of risperidone without the use of organic solvents. The kinetics of release of risperidone from polymer microparticles in saline solution was studied by UV spectrophotometry. It was shown that the use of D,L-polylactides of various molecular weights makes it possible to achieve a controlled increase in the time of release of risperidone from bioresorbable polymer particles prepared via the PGSS technique up to ten days.

About the authors

V. N. Bagratashvili

Institute of Laser and Information Technologies

Email: popov@laser.ru
Russian Federation, Moscow

S. E. Bogorodskii

Institute of Laser and Information Technologies

Email: popov@laser.ru
Russian Federation, Moscow

A. M. Egorov

Department of Chemistry

Email: popov@laser.ru
Russian Federation, Moscow

L. I. Krotova

Institute of Laser and Information Technologies

Email: popov@laser.ru
Russian Federation, Moscow

V. K. Popov

Institute of Laser and Information Technologies

Author for correspondence.
Email: popov@laser.ru
Russian Federation, Moscow

V. I. Sevast’yanov

Federal Research Center of Transplantology and Artificial Organs

Email: popov@laser.ru
Russian Federation, Moscow

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Ltd.